Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome

Psychosomatic Medicine

Volumn 75, Issue 3, 2013, Pages 326-330

  Van Roie, Elke ^a   Labarque, Veerle ^a   Renard, Marleen ^a   Van Geet, Christel ^a   Gabriëls, Loes ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

anticoagulants; antiphospholipid syndrome; basal ganglia; caudate nucleus; Hughes syndrome; obsessive compulsive disorder

Indexed keywords

ENOXAPARIN; PHENPROCOUMON; RISPERIDONE; SERTRALINE;

ADOLESCENT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ANXIETY; ARTERY THROMBOSIS; ARTICLE; BRAIN INFARCTION; CASE REPORT; CAUDATE NUCLEUS; CEREBROVASCULAR ACCIDENT; COGNITIVE THERAPY; CROHN DISEASE; EMERGENCY WARD; HAND WASHING; HEART INFARCTION; HUMAN; LANGUAGE DEVELOPMENT; LEG PAIN; MALE; MENTAL DISEASE; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; URINALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84876295184     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31828acfbc     Document Type: Article

References (34)

1. Rapoport JL, Shaw P. Obsessive-compulsive disorder. In: Rutter M, Bishop D, Pine D, Scott S, Stevenson J, Taylor E, Thapar A, editors. Rutter's Child and Adolescent Psychiatry. 5th ed. UK: Wiley-Blackwell; 2008.
2. Stein DJ. Obsessive-compulsive disorder. Lancet 2002;360:397-405.
3. Maia TV, Cooney RE, Peterson BS. The neural bases of obsessive-compulsive disorder in children and adults. Dev Psychopathol 2008;20: 1251-83.
4. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsycho-logical studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008;32:525-49.
5. Alexander GE, Delong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-81.
6. Chacko RC, Corbin MA, Harper RG. Acquired obsessive-compulsive disorder associated with basal ganglia lesions. J Neuropsychiatry Clin Neurosci 2000;12:269-72.
7. Koppel BH, Greenberg BD. Anatomy and physiology of the basal ganglia: implications for DBSinpsychiatry. Neurosci Biobehav Rev 2008;32:408-22.
8. Radua J, Van den Heuvel OA, Surguladze S, Mataix-Cols D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 2010;67:701-11.
9. Braun CMJ, Leveille C, Guimond A. An orbitofrontostriatopalidal pathway for morality: evidence from postlesion antisocial and obsessive-compulsive disorder. Cogn Neuropsychiatry 2008;13:296-337.
10. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004;113:883-6.
11. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 2010;20:317-31.
12. Sanna G, Bertolaccini ML, Hughes GR. Hughes syndrome, the antiphos-pholipid syndrome: a new chapter in neurology. Ann N YAcad Sci 2005; 1051:465-86.
13. Oken RJ. Obsessive-compulsive disorder: a neuronal membrane phos-pholipid hypothesis and concomitant therapeutic strategy. Med Hypotheses 2001;56:413-5.
14. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 2006;114: 2170-7.
15. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, Michelson AD, American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic Treatment and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e737-e804.
16. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER;, American Heart Association Stroke Council; Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008;39: 2644-91.
17. Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG, Landenberg Pv, Shoenfeld Y, Chapman J. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis 2008;30:56-64.
18. Sun SS, Liu FY, Tsai JJP, Yen RF, Kao CH, Huang WS. Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvementVa preliminary report. Rheumatol Int 2003;23:301-4.
19. Sanna G, Bertolaccini ML, Khamashta MA. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach. Curr Pharm Des 2008;14:1261-9.
20. Cuadrado MJ, Khamashta MA, Hughes GRV. Sticky blood and headache. Lupus 2001;10:392-3.
21. Hughes GRV, Cuadrado MJ, Khamashta MA, Sanna G. Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome. Lupus 2001;10:778.
22. AACAP. Practice parameters for the assessment en treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998;37(suppl 10):27S-45S.
23. National Institute for mental health and Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. Clinical Guidelines 2005. Available at: http://publications.nice.org.uk/obsessive-compulsive- disorder-cg31.
24. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007;164:5-53.
25. Lewin AB, Piacentini J. Evidence-based assessment of child obsessive-compulsive disorder: recommendations for clinical practice and treatment research. Child Youth Care Forum 2010;39:73-89.
26. Stafford B, Boris NW, Dalton R. Anxiety disorders. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson Textbook of Pediatrics. 18th ed. USA: Saunders Elsevier; 2007.
27. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neu-ropsychiatric disorders associated with streptococcal infections: clinical description of the first fifty cases. Am J Psychiatry 1998;155:264-71.
28. Snider LA, Swedo SE. Childhood onset obsessive-compulsive disorder and tic disorders: case report en literature review. J Child Adolesc Psychopharmacol 2003;13:81-8.
29. The Pediatric OCD Treatment Study Team. Cognitive-behavior therapy, sertraline and their combination for children and adolescents with obsessive-compulsive disorder. the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004;292:1969-76.
30. Gilbert AR, Maalouf FT. Pediatric obsessive-compulsive disorder: management in primary care. Curr Opin Pediatr 2008;20:544-50.
31. Watson HJ, Rees CS. Meta-analysis of randomized controlled treatment trials for pediatric obsessive-compulsive disorder. J Clin Pschol Psychiatry 2008;49:489-98.
32. Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL, Witowski ME, Dubbert B, Swedo SE. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999;45:1564-71.
33. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsy-chiatric disorders. Biol Psychiatry 2005;57:788-92.
34. Perlmutter SJ, Leitman SF, Garvey A, Hamburger S, Feldman E, Leonard HL. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354:153-8.